Evaluating Efficacy of Antimicrobial and Antifouling Materials for Urinary Tract Medical Devices: Challenges and Recommendations

creativework.keywordsantimicrobial, device-associated urinary tract infections, in vitro, in vivo, material testing
creativework.publisherWiley-VCH Verlaginfo@wiley-vch.deen
dc.contributor.authorRamstedt M.
dc.contributor.authorRibeiro I.A.C.
dc.contributor.authorBujdakova H.
dc.contributor.authorMergulhão F.J.M.
dc.contributor.authorJordao L.
dc.contributor.authorThomsen P.
dc.contributor.authorAlm M.
dc.contributor.authorBurmølle M.
dc.contributor.authorVladkova T.
dc.contributor.authorCan F.
dc.contributor.authorReches M.
dc.contributor.authorRiool M.
dc.contributor.authorBarros A.
dc.contributor.authorReis R.L.
dc.contributor.authorMeaurio E.
dc.contributor.authorKikhney J.
dc.contributor.authorMoter A.
dc.contributor.authorZaat S.A.J.
dc.contributor.authorSjollema J.
dc.date.accessioned2024-07-10T14:27:04Z
dc.date.accessioned2024-07-10T14:49:06Z
dc.date.available2024-07-10T14:27:04Z
dc.date.available2024-07-10T14:49:06Z
dc.date.issued2019-05-01
dc.description.abstractIn Europe, the mean incidence of urinary tract infections in intensive care units is 1.1 per 1000 patient-days. Of these cases, catheter-associated urinary tract infections (CAUTI) account for 98%. In total, CAUTI in hospitals is estimated to give additional health-care costs of £1–2.5 billion in the United Kingdom alone. This is in sharp contrast to the low cost of urinary catheters and emphasizes the need for innovative products that reduce the incidence rate of CAUTI. Ureteral stents and other urinary-tract devices suffer similar problems. Antimicrobial strategies are being developed, however, the evaluation of their efficacy is very challenging. This review aims to provide considerations and recommendations covering all relevant aspects of antimicrobial material testing, including surface characterization, biocompatibility, cytotoxicity, in vitro and in vivo tests, microbial strain selection, and hydrodynamic conditions, all in the perspective of complying to the complex pathology of device-associated urinary tract infection. The recommendations should be on the basis of standard assays to be developed which would enable comparisons of results obtained in different research labs both in industry and in academia, as well as provide industry and academia with tools to assess the antimicrobial properties for urinary tract devices in a reliable way.
dc.identifier.doi10.1002/mabi.201800384
dc.identifier.issn1616-5195
dc.identifier.issn1616-5187
dc.identifier.scopusSCOPUS_ID:85065484534en
dc.identifier.urihttps://rlib.uctm.edu/handle/123456789/529
dc.language.isoen
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065484534&origin=inward
dc.titleEvaluating Efficacy of Antimicrobial and Antifouling Materials for Urinary Tract Medical Devices: Challenges and Recommendations
dc.typeReview
oaire.citation.issue5
oaire.citation.volume19
Files
Collections